Tenax Therapeutics (TENX) Non-cash Items (2023 - 2024)
Tenax Therapeutics (TENX) posted quarterly Non-cash Items of -$5.2 million for Q1 2024, down 199.48% year-over-year from $5.2 million in Q2 2023, and down 199.48% on a QoQ basis from -$1.7 million in Q1 2023.
Tenax Therapeutics (TENX) Non-cash Items (2023 - 2024) Analysis & Trends
Tenax Therapeutics has reported Non-cash Items for 2 years, with the latest figure at -$5.2 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Tenax Therapeutics | 79.60 Mn | 79.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -5.17 Mn |
| Mar 31, 2024 | -5.17 Mn |
| Mar 31, 2023 | -1.72 Mn |
| Mar 31, 2023 | -1.72 Mn |